| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |